163 related articles for article (PubMed ID: 8077362)
1. Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content.
Lockwood CJ; Krikun G; Papp C; Aigner S; Nemerson Y; Schatz F
J Clin Endocrinol Metab; 1994 Sep; 79(3):786-90. PubMed ID: 8077362
[TBL] [Abstract][Full Text] [Related]
2. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
3. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
[TBL] [Abstract][Full Text] [Related]
4. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation.
Lockwood CJ; Krikun G; Papp C; Toth-Pal E; Markiewicz L; Wang EY; Kerenyi T; Zhou X; Hausknecht V; Papp Z
Ann N Y Acad Sci; 1994 Sep; 734():57-79. PubMed ID: 7978955
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells.
Krikun G; Schatz F; Mackman N; Guller S; Lockwood CJ
J Clin Endocrinol Metab; 1998 Mar; 83(3):926-30. PubMed ID: 9506750
[TBL] [Abstract][Full Text] [Related]
6. Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation.
Lockwood CJ; Nemerson Y; Krikun G; Hausknecht V; Markiewicz L; Alvarez M; Guller S; Schatz F
J Clin Endocrinol Metab; 1993 Oct; 77(4):1014-9. PubMed ID: 8408448
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.
Krikun G; Schatz F; Mackman N; Guller S; Demopoulos R; Lockwood CJ
Mol Endocrinol; 2000 Mar; 14(3):393-400. PubMed ID: 10707957
[TBL] [Abstract][Full Text] [Related]
8. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
10. Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells.
Schatz F; Lockwood CJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):621-5. PubMed ID: 8370684
[TBL] [Abstract][Full Text] [Related]
11. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells.
Schatz F; Papp C; Toth-Pal E; Lockwood CJ
J Clin Endocrinol Metab; 1994 Jun; 78(6):1467-72. PubMed ID: 8200951
[TBL] [Abstract][Full Text] [Related]
12. Expression of 11 beta-hydroxysteroid dehydrogenase during decidualization of human endometrial stromal cells.
Arcuri F; Monder C; Lockwood CJ; Schatz F
Endocrinology; 1996 Feb; 137(2):595-600. PubMed ID: 8593807
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
Lockwood CJ
Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
[TBL] [Abstract][Full Text] [Related]
15. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells.
Huang JR; Tseng L; Bischof P; Jänne OA
Endocrinology; 1987 Dec; 121(6):2011-7. PubMed ID: 2960516
[TBL] [Abstract][Full Text] [Related]
16. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis.
Schatz F; Krikun G; Caze R; Rahman M; Lockwood CJ
Steroids; 2003 Nov; 68(10-13):849-60. PubMed ID: 14667977
[TBL] [Abstract][Full Text] [Related]
17. Effects of thrombin, hypoxia, and steroids on interleukin-8 expression in decidualized human endometrial stromal cells: implications for long-term progestin-only contraceptive-induced bleeding.
Lockwood CJ; Kumar P; Krikun G; Kadner S; Dubon P; Critchley H; Schatz F
J Clin Endocrinol Metab; 2004 Mar; 89(3):1467-75. PubMed ID: 15001649
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells.
Casey ML; MacDonald PC
J Clin Endocrinol Metab; 1996 Nov; 81(11):4022-7. PubMed ID: 8923854
[TBL] [Abstract][Full Text] [Related]
19. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
Tseng L; Mazella J; Sun B
Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597
[TBL] [Abstract][Full Text] [Related]
20. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
